Woodline Partners’s Evolus EOLS Stock Holding History

Woodline Partners’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-393,222	Closed	-$2.41M	–	1051
2025 Q3	$2.41M	Buy	393,222 +188,660	+92%	+$1.47M	0.01%	699
2025 Q2	$1.88M	Buy	+204,562	New	+$2.09M	0.01%	730

Other funds holding EOLS

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Woodline Partners's EOLS Position: Q4 2025 in Review

Woodline Partners sold out of Evolus (EOLS) in Q4 2025, closing a stake of 393,222 shares — an estimated $2.41M sold.

Woodline Partners first reported a position in EOLS in Q2 2025 and held it in 2 quarters. The position peaked at $2.41M in Q3 2025. 169 funds tracked by Wall St. Rank hold EOLS as of Q4 2025.

Woodline Partners reported no remaining Evolus position as of Q4 2025 after selling out during the quarter.
Woodline Partners sold 393,222 Evolus shares in Q4 2025, an estimated $2.41M.
Woodline Partners first reported a position in Evolus in Q2 2025 and held it in 2 quarters.
Woodline Partners's Evolus position peaked at $2.41M in Q3 2025.
169 funds tracked by Wall St. Rank held Evolus as of Q4 2025.

Based on Woodline Partners's 13F filing for Q4 2025, filed 17 Feb 2026.